Actively Recruiting
Using PETMRI to Assess How Well Neoadjuvant Therapy Works in Patients with Locally Advanced Rectal Cancer
Led by Peking Union Medical College Hospital · Updated on 2024-10-22
30
Participants Needed
1
Research Sites
74 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying patients with Locally Advanced Rectal Cancer LARC who are receiving neoadjuvant therapy to assess the effectiveness of this treatment. The study compares changes in the primary rectal lesion, lymph node involvement, local tumor infiltration, and distant metastases before and after therapy. The evaluation uses surgical pathology as the gold standard and aims to compare the diagnostic performance of PETMR scans using two tracers, 18F-FDG and 68Ga-FAPI, alongside traditional PETCT and rectal MRI scans. Participants undergo 68Ga-FAPI-04 PETCT and PETMR scans, followed by 18F-FDG PETCT and PETMR scans within one week before and after these examinations. These imaging tests are conducted before treatment and again before surgery after neoadjuvant therapy to assess changes. The study evaluates the advantages and disadvantages of each imaging method for predicting treatment response. During the study, participants will have multiple imaging examinations, including PETCT and PETMR scans, before and after therapy. Researchers will measure diagnostic accuracy, sensitivity, and specificity to determine how well each imaging technique predicts treatment effectiveness. The study will last about one year, with ongoing assessments to track tumor stage changes and treatment outcomes. Safety and adherence to study procedures will be monitored throughout the trial.
CONDITIONS
Brief Title
Application of PET/MRI in the Evaluation of the Efficacy of Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Research Team
Z
Zhaoxia huang, B.S.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here